India, Aug. 14 -- Biomerica, Inc. (BMRA) rose 21.53 percent to $3.67, gaining $0.65 on Thursday, after the UAE Ministry of Health and Prevention approved its Fortel Ulcer Test for home use. The rapid 10-minute diagnostic detects antibodies to Helicobacter pylori, a bacterium linked to peptic ulcers, chronic digestive pain, and up to 80 percent of gastric cancer cases.
The stock opened at $4.19 and traded between $3.55 and $4.60, with 37.67 million shares exchanged, compared with an average daily volume of 52,012 on the Nasdaq.
Biomerica's 52-week range is $2.08 to $10.16.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....